| 764528 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
808 Tertiary lymphoid structure gene signature detected in immune checkpoint inhibitor-associated renal immune related adverse event |
2021-11-01 |
10.1136/jitc-2021-sitc2021.808 |
Lin Jamie, Tchakarov Amanda, Abdel-Wahab Noha, Safa Houssein, Bentebibel Salah-Eddine, Abdelrahim Maen, Yee Cassian, Diab Adi, Abudayyeh Ala |
| 764527 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
900 Depleting non-canonical, cell-intrinsic PD-L1 signals induces synthetic lethality to small molecule DNA damage response inhibitors in an immune independent and dependent manner |
2021-11-01 |
10.1136/jitc-2021-sitc2021.900 |
Kornepati Anand, Murray Clare, Avalos Barbara, Rogers Cody, Ramkumar Kavya, Gupta Harshita, Deng Yilun, Liu Zexuan, Padron Alvaro, Vadlamudi Ratna, Dray Eloise, Zhao Weixing, Sung Patrick, Byers Lauren, Curiel Tyler |
| 764526 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
45 AI-assisted whole-body assessment of immunotherapy response using [18F]F-AraG, a PET agent for activated T cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.045 |
Levi Jelena, Perk Timothy, Huynh Lyna, Packiasamy Juliet, Cheng Serena, Sunwoo John, Dimitrios Colevas A |
| 764525 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
253 PD1 and LAG3 converge to limit polyfunctionality and systemic immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.253 |
Andrews Lawrence, Manne Sasikanth, John Wherry E, Workman Creg, Vignali Dario |
| 764524 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
619 Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.619 |
Verma Svena, Maniyar Rachana, Ko Myat, Budhu Sadna, Serganova Inna, Zappasodi Roberta, Blasberg Ronald, Merghoub Taha, Wolchok Jedd, Mangarin Levi |
| 764523 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
61 Biomarkers of favorable prognosis guides the identification of tumor reactive CD4+ and CD8+ TILs in endometrial cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.061 |
Palomero Jara, Panisello Carla, Vidal August, Ponce Jordi, Vivancos Ana, Piulats Josep Maria, Matias-Guiu Xavier, Gros Alena |
| 764522 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
60 Use of the Combined Positive Score (CPS) with the companion diagnostic PD-L1 IHC 22C3 pharmDx provides precise evaluation of PD-L1 expression across multiple tumor indications and cutoffs |
2021-11-01 |
10.1136/jitc-2021-sitc2021.060 |
Ponce Francisco, Hund Stephanie, Peltz Lindsay, Placa Chris La, Vilardo Monika, Watts Brittany, Tabuena-Frolli Siena, Toland Grant, Posch Alex, Milo Jay, Kulangara Karina, Apostolaki Angeliki |
| 764521 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
55 Baseline glycolytic tumor burden predicts response and survival in NSCLC and melanoma patients treated with immune checkpoint inhibitors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.055 |
Silva Saulo, Wanderley Carlos Wagner, Marin Jose Flavio, Macedo Mariana De, Nascimento Ellen, Antonacio Fernanda, Cunha Fernando, Castro Gilberto de |
| 764520 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
53 Unique insights into PDAC development revealed by both InSituPlex® and imaging mass cytometry |
2021-11-01 |
10.1136/jitc-2021-sitc2021.053 |
Quong Andrew, Rees Mark, Maclean Kirsteen, Manesse Mael, Nieto Jordan, Esch Amanda, Fleury Devan, Wharton Keith, Chatterjee Gourab |
| 764519 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
52 Characterization of the tumor microenvironment in melanoma using Multiplexed Ion Beam Imaging (MIBI) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.052 |
Ptacek Jason, Vesely Matthew, Rimm David, Hav Monirath, Aksoy Murat, Crow Ailey, Finn Jessica |
